| 000 | 01840 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515174737.0 | ||
| 264 | 0 | _c20091211 | |
| 008 | 200912s 0 0 eng d | ||
| 022 | _a0924-9338 | ||
| 024 | 7 |
_a10.1016/j.eurpsy.2009.03.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aClark, D | |
| 245 | 0 | 0 |
_aApolipoprotein-E gene variants associated with cardiovascular risk factors in antipsychotic recipients. _h[electronic resource] |
| 260 |
_bEuropean psychiatry : the journal of the Association of European Psychiatrists _cOct 2009 |
||
| 300 |
_a456-63 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
| 650 | 0 | 4 |
_aApolipoproteins E _xgenetics |
| 650 | 0 | 4 | _aBody Mass Index |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xgenetics |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xgenetics |
| 650 | 0 | 4 | _aGenetic Carrier Screening |
| 650 | 0 | 4 |
_aGenetic Predisposition to Disease _xgenetics |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHomozygote |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypercholesterolemia _xgenetics |
| 650 | 0 | 4 |
_aHyperlipidemias _xgenetics |
| 650 | 0 | 4 |
_aHypertension _xgenetics |
| 650 | 0 | 4 |
_aObesity _xgenetics |
| 650 | 0 | 4 |
_aPolymorphism, Genetic _xgenetics |
| 650 | 0 | 4 |
_aPolymorphism, Single Nucleotide _xgenetics |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aRisperidone _xadverse effects |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 700 | 1 | _aSkrobot, O A | |
| 700 | 1 | _aAdebiyi, I | |
| 700 | 1 | _aSusce, M T | |
| 700 | 1 | _ade Leon, J | |
| 700 | 1 | _aBlakemore, Ai F | |
| 700 | 1 | _aArranz, M J | |
| 773 | 0 |
_tEuropean psychiatry : the journal of the Association of European Psychiatrists _gvol. 24 _gno. 7 _gp. 456-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.eurpsy.2009.03.003 _zAvailable from publisher's website |
| 999 |
_c18959595 _d18959595 |
||